Fusion protein MICA-G129R was confirmed not only able to bind to PRLR-positive breast cancer cells and NK cells (Fig 2), but also enhance cytotoxicity of NK cells on PRLR-positive cells (Fig 3A and 3C). The gene discussed is MICA; the disease is breast carcinoma.